Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
Public ClinicalTrials.gov record NCT00596466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Multicenter Extension Study To Determine Long Term Safety And Efficacy Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.
Study identification
- NCT ID
- NCT00596466
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Dec 2011 (Actual)
- Last update posted
- Jan 26, 2021
2008 – 2011
United States locations
- U.S. sites
- 34
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | 85003 | — |
| Pfizer Investigational Site | Fayetteville | Arkansas | 72703 | — |
| Pfizer Investigational Site | Fullerton | California | 92835 | — |
| Pfizer Investigational Site | Long Beach | California | 90806 | — |
| Pfizer Investigational Site | Modesto | California | 95355 | — |
| Pfizer Investigational Site | Murrieta | California | 92562 | — |
| Pfizer Investigational Site | Newport Beach | California | 92660 | — |
| Pfizer Investigational Site | Temecula | California | 92591 | — |
| Pfizer Investigational Site | Denver | Colorado | 80204 | — |
| Pfizer Investigational Site | Jacksonville | Florida | 32209 | — |
| Pfizer Investigational Site | Suwanee | Georgia | 30024 | — |
| Pfizer Investigational Site | Danville | Indiana | 46122 | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | 46805 | — |
| Pfizer Investigational Site | Kansas City | Kansas | 66160 | — |
| Pfizer Investigational Site | Bowling Green | Kentucky | 42101 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40536 | — |
| Pfizer Investigational Site | Houma | Louisiana | 70363 | — |
| Pfizer Investigational Site | Shreveport | Louisiana | 71105-5634 | — |
| Pfizer Investigational Site | Pikesville | Maryland | 21208 | — |
| Pfizer Investigational Site | Worcester | Massachusetts | 01608 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | Flowood | Mississippi | 39232 | — |
| Pfizer Investigational Site | Great Falls | Montana | 59405 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28203 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28209 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43210 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | 73120 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Houston | Texas | 77074 | — |
| Pfizer Investigational Site | Temple | Texas | 76508 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84107 | — |
| Pfizer Investigational Site | West Jordan | Utah | 84088 | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00596466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2021 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00596466 live on ClinicalTrials.gov.